Diamond Member Pelican Press 0 Posted July 3, 2025 Diamond Member Share Posted July 3, 2025 Can a single injection truly revolutionize **** prevention? That’s the question on the minds of healthcare professionals and at-risk communities as Gilead Sciences rolls out its new long-acting injectable drug, Yeztugo. Approved for pre-exposure prophylaxis (PrEP), Yeztugo offers a potentially game-changing alternative to daily oral medications, promising increased adherence and convenience. This is the hidden content, please Sign In or Sign Up 0 Quote Link to comment https://hopzone.eu/forums/topic/281461-gilead%E2%80%99s-yeztugo-injection-offers-new-hope-in-hiv-prevention-but-access-remains-a-key-challenge/ Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.